annual D&A:
$322.34M+$124.07M(+62.57%)Summary
- As of today (August 18, 2025), BNTX annual depreciation & amortization is $322.34 million, with the most recent change of +$124.07 million (+62.57%) on December 31, 2024.
- During the last 3 years, BNTX annual D&A has risen by +$233.46 million (+262.65%).
- BNTX annual D&A is now at all-time high.
Performance
BNTX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$56.94M+$11.89M(+26.40%)Summary
- As of today (August 18, 2025), BNTX quarterly depreciation & amortization is $56.94 million, with the most recent change of +$11.89 million (+26.40%) on June 30, 2025.
- Over the past year, BNTX quarterly D&A has increased by +$3.23 million (+6.02%).
- BNTX quarterly D&A is now -68.44% below its all-time high of $180.39 million, reached on December 31, 2024.
Performance
BNTX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$330.79M+$3.23M(+0.99%)Summary
- As of today (August 18, 2025), BNTX TTM depreciation & amortization is $330.79 million, with the most recent change of +$3.23 million (+0.99%) on June 30, 2025.
- Over the past year, BNTX TTM D&A has increased by +$107.14 million (+47.91%).
- BNTX TTM D&A is now at all-time high.
Performance
BNTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BNTX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.6% | +6.0% | +47.9% |
| 3 y3 years | +262.6% | +59.8% | +175.3% |
| 5 y5 years | +749.7% | +490.3% | +736.5% |
BNTX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +262.6% | -68.4% | +101.9% | at high | +175.3% |
| 5 y | 5-year | at high | +749.7% | -68.4% | +490.3% | at high | +736.5% |
| alltime | all time | at high | +2688.7% | -68.4% | +597.6% | at high | +3952.9% |
BNTX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $56.94M(+26.4%) | $330.79M(+1.0%) |
| Mar 2025 | - | $45.05M(-75.0%) | $327.55M(+1.1%) |
| Dec 2024 | $322.34M(+62.6%) | $180.39M(+272.6%) | $324.07M(+42.9%) |
| Sep 2024 | - | $48.41M(-9.9%) | $226.85M(+1.4%) |
| Jun 2024 | - | $53.70M(+29.2%) | $223.64M(+9.2%) |
| Mar 2024 | - | $41.57M(-50.0%) | $204.84M(+4.0%) |
| Dec 2023 | $198.28M(+53.0%) | $83.17M(+84.0%) | $196.97M(+38.7%) |
| Sep 2023 | - | $45.20M(+29.5%) | $142.00M(+8.7%) |
| Jun 2023 | - | $34.91M(+3.6%) | $130.60M(-0.6%) |
| Mar 2023 | - | $33.69M(+19.5%) | $131.33M(+2.1%) |
| Dec 2022 | $129.59M(+45.8%) | $28.20M(-16.6%) | $128.60M(-1.4%) |
| Sep 2022 | - | $33.80M(-5.1%) | $130.47M(+8.6%) |
| Jun 2022 | - | $35.63M(+15.1%) | $120.17M(+15.2%) |
| Mar 2022 | - | $30.96M(+2.9%) | $104.28M(+17.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $88.89M(+101.2%) | $30.08M(+28.0%) | $88.98M(+20.3%) |
| Sep 2021 | - | $23.50M(+19.0%) | $73.98M(+22.0%) |
| Jun 2021 | - | $19.75M(+26.1%) | $60.65M(+20.0%) |
| Mar 2021 | - | $15.66M(+3.8%) | $50.55M(+14.0%) |
| Dec 2020 | $44.17M(+16.4%) | $15.08M(+48.3%) | $44.36M(+9.7%) |
| Sep 2020 | - | $10.17M(+5.4%) | $40.45M(+2.3%) |
| Jun 2020 | - | $9.65M(+1.9%) | $39.54M(+0.7%) |
| Mar 2020 | - | $9.47M(-15.2%) | $39.26M(+3.4%) |
| Dec 2019 | $37.94M(+46.3%) | $11.17M(+20.6%) | $37.95M(+41.7%) |
| Sep 2019 | - | $9.26M(-1.0%) | $26.78M(+52.9%) |
| Jun 2019 | - | $9.36M(+14.7%) | $17.52M(+114.7%) |
| Mar 2019 | - | $8.16M | $8.16M |
| Dec 2018 | $25.94M(+124.4%) | - | - |
| Dec 2017 | $11.56M | - | - |
FAQ
- What is BioNTech SE annual depreciation & amortization?
- What is the all time high annual D&A for BioNTech SE?
- What is BioNTech SE annual D&A year-on-year change?
- What is BioNTech SE quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BioNTech SE?
- What is BioNTech SE quarterly D&A year-on-year change?
- What is BioNTech SE TTM depreciation & amortization?
- What is the all time high TTM D&A for BioNTech SE?
- What is BioNTech SE TTM D&A year-on-year change?
What is BioNTech SE annual depreciation & amortization?
The current annual D&A of BNTX is $322.34M
What is the all time high annual D&A for BioNTech SE?
BioNTech SE all-time high annual depreciation & amortization is $322.34M
What is BioNTech SE annual D&A year-on-year change?
Over the past year, BNTX annual depreciation & amortization has changed by +$124.07M (+62.57%)
What is BioNTech SE quarterly depreciation & amortization?
The current quarterly D&A of BNTX is $56.94M
What is the all time high quarterly D&A for BioNTech SE?
BioNTech SE all-time high quarterly depreciation & amortization is $180.39M
What is BioNTech SE quarterly D&A year-on-year change?
Over the past year, BNTX quarterly depreciation & amortization has changed by +$3.23M (+6.02%)
What is BioNTech SE TTM depreciation & amortization?
The current TTM D&A of BNTX is $330.79M
What is the all time high TTM D&A for BioNTech SE?
BioNTech SE all-time high TTM depreciation & amortization is $330.79M
What is BioNTech SE TTM D&A year-on-year change?
Over the past year, BNTX TTM depreciation & amortization has changed by +$107.14M (+47.91%)